<Suppliers Price>

TIK-301

Names

[ CAS No. ]:
118702-11-7

[ Name ]:
TIK-301

[Synonym ]:
N-[(2R)-2-(6-Chloro-5-methoxy-1H-indol-3-yl)propyl]acetamide
Acetamide, N-[(2R)-2-(6-chloro-5-methoxy-1H-indol-3-yl)propyl]-
LY-156,735
PD-6735
3ZX95B1ZWK
TIK-301

Biological Activity

[Description]:

TIK-301 (PD-6735) is a chlorinated melatonin derivative and a potent, high-affinity and orally active melatonin MT1 and MT2 receptors agonist with Kis of 0.081 nM and 0.042 nM, respectively. TIK-301 is also a 5-HT2B/5-HT2C receptors antagonist with antidepressant action. TIK-301 has the potential for sleep disorders and other circadian rhythm disorders treatment[1][2][3].

[Related Catalog]:

Signaling Pathways >> Neuronal Signaling >> Melatonin Receptor
Signaling Pathways >> GPCR/G Protein >> Melatonin Receptor
Research Areas >> Neurological Disease
Signaling Pathways >> GPCR/G Protein >> 5-HT Receptor
Signaling Pathways >> Neuronal Signaling >> 5-HT Receptor

[Target]

melatonin MT1:0.081 nM (Ki)

melatonin MT2:0.042 nM (Ki)

5-HT2C Receptor

5-HT2B Receptor


[In Vivo]

In male rats, TIK-301(at doses of 0.8 and 4.0 mg/kg/day) can reduce body weight, and without altering food intake[1][2]. The Tmax and half-life of TIK-301 is 1.1 hour and 1 hour, respectively[1].

[References]

[1]. Paulis L, et al. Cardiovascular effects of melatonin receptor agonists. Expert Opin Investig Drugs. 2012 Nov;21(11):1661-78.

[2]. Rivara S, et al. Melatonin receptor agonists: SAR and applications to the treatment of sleep-wake disorders. Curr Top Med Chem. 2008;8(11):954-68.

[3]. Carocci A, et al. Melatonergic drugs in development. Clin Pharmacol. 2014 Sep 18;6:127-37.

Chemical & Physical Properties

[ Density]:
1.2±0.1 g/cm3

[ Boiling Point ]:
525.9±50.0 °C at 760 mmHg

[ Molecular Formula ]:
C14H17ClN2O2

[ Molecular Weight ]:
280.750

[ Flash Point ]:
271.9±30.1 °C

[ Exact Mass ]:
280.097870

[ LogP ]:
1.86

[ Vapour Pressure ]:
0.0±1.4 mmHg at 25°C

[ Index of Refraction ]:
1.596


Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.